CENCORA
"CENCORA" is a word mark owned by Cencora, Inc., filed at the EUIPO on June 7, 2024. It is registered and covers classes 35, 39, 40, 41, 42, 44 and 45.
- Status
- Registered
- Since December 10, 2024
- Filed
- June 7, 2024
- Registered
- December 6, 2024
- Expires
- June 7, 2034
- Application no.
- 019038641
- Registration no.
- 019038641
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 7 classes
Who owns CENCORA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Cencora, Inc.
COR
Representative
Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius LLP
What the mark covers
The products and services CENCORA is filed for, grouped by Nice class.
Outsourcing services in the field of business management for companies engaged in the field of medicine development, authorization, production, sale, safety and monitoring; consumer research services in the field of drug safety; business management services in the field of clinical trials, namely, compilation and management of regulatory submission data on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting services in the field of medical clinical trials management; assistance and consultancy in the field of business management of companies engaged in medicine and medical device authorization and lifecycle maintenance, namely, automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval; regulatory submission management, namely, assisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documents, reports and files required by regulatory authorities via automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval; acquisition and merger consultation; advertising, management of business for others, business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; providing outsourced office functions services for drug approval, manufacturing, distribution, security and monitoring; assistance and consultancy in the context of the retailing and wholesaling of medicines; consultancy services in the fields of controlling and managing business information and implementing and managing databases
Support and advice in the context of drug distribution in retail and wholesale
Assistance and consultancy in the context of medicine production, namely, manufacturing process consulting
Educational services, namely, conducting online exhibitions, displays and exhibits in the field of pharmacovigilance, biosimilars, medical products, medical services, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, medicines and medical products; providing of training services, for others, in the field of pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products
Scientific and technological services and research and design relating thereto, namely, new product design and scientific research in the field of pharmacovigilance, clinical data review, chemistry data evaluation; scientific research and laboratory research, all in the field of pharmaceuticals, medicines and medical products; industrial analysis and research services, namely, laboratory research services relating to pharmaceuticals, pharmaceutical research services, and research and development of new products for others; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; information technology services for the pharmaceutical and healthcare industries, namely, information technology consulting services; quality control testing; materials testing and evaluation; product safety testing; providing medical and scientific research information in the fields of pharmaceuticals, drug safety, clinical research, clinical testing and clinical trials; scientific and technological services and research and design relating thereto; scientific, technological, medical and pharmaceutical research and development services; industrial analysis and research services; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific, technological, medical and pharmaceutical research services and analysis services for scientific and technological purposes; biological research; clinical research; providing medical and scientific research information; provision of surveys (scientific); scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics; development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents; database services, namely, storage of data in computer databases; conversion of data or documents from physical to electronic media; testing, inspection or research of pharmaceuticals and medicines; design, engineering, research, development and testing services; research in the field of gene therapy; quality assurance, quality control and quality management consultancy; research services relating to scientific work; preparation of scientific analyzes and evaluations; development of pharmaceutical preparations and medicines; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; information technology services for the pharmaceutical and healthcare industries; scientific evaluation of drug efficacy; services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design; analysis and evaluation of product development; certification (quality control); quality testing of products for certification purposes; support and advice on drug safety and monitoring; consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics
Medical services; veterinary services; pharmacy advice; providing information relating to the preparation and dispensing of medications; provision of pharmaceutical information; provision of information relating to medicine; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; advisory services relating to pharmaceuticals; medical, diagnostic and pharmaceutical services and advice; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses; medical, diagnostic and pharmaceutical services and advice in the field of drug safety; providing information in the field of pharmacovigilance and adverse event reporting; Consulting services for others in relation to project management (namely design, planning, and implementation project management) in the field of pharmaceuticals, medicines and medical products; Consulting services for others in relation to project management (namely design, planning, and implementation project management) of clinical trials; laboratory analysis service relating to the diagnosis and treatment of persons
Legal services; Legal assistance for the filing of applications for medicine marketing authorisations featuring documents, reports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals; regulatory compliance consulting in the field of clinical trials, pharmacovigilance, clinical data review, chemistry data evaluation, scientific research, and laboratory research in the field of pharmaceuticals, biosimilars, medicines and medical products; regulatory research in the field of health care; regulatory compliance auditing; regulatory compliance consulting services; regulatory support and advice in the context of drug approval; submission of documents, reports and records required for drug approval by regulatory authorities (regulatory compliance auditing); consultancy services in the fields of regulatory compliance and oversight; advisory services relating to regulatory affairs; regulatory maintenance of marketing authorizations following approval
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2024/236 Section B.1
- Bulletin 2024/165 Section A.1
About CENCORA
Who owns the trademark "CENCORA"?
The EUIPO trademark "CENCORA" (application 019038641) is owned by Cencora, Inc.
What is the status of "CENCORA"?
Its status at the EUIPO is: registered.
When was "CENCORA" registered?
It was registered on December 6, 2024 and is due to expire on June 7, 2034.
Get this data via the API
Everything on this page comes from the Signa API. Pull CENCORA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d4621-69ea-71e5-84dd-d4c977e86c2d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d4621-69ea-71e5-84dd-d4c977e86c2d",
"object": "trademark",
"mark_text": "CENCORA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "019038641",
"filing_date": "2024-06-07",
"nice_classes": [
35,
39,
40,
41,
42,
44,
45
],
"owners": [
{
"name": "Cencora, Inc.",
"entity_id": "ent_019ebbf1-fb37-770a-88c0-e6dfb29d2c05"
}
]
}